(Q46560338)
Statements
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab (English)
M F Leahy
J H Turner
A D McQuillan